How to use Virgan 1,5 mg/g zhel do ohu
Contents of the leaflet
- Package Leaflet: Information for the User
- Warning! Keep the leaflet. Information on the immediate packaging in a foreign language.
- Virgan 1.5 mg/g eye gel
- What is Virgan and what is it used for
- Important information before using Virgan
- How to use Virgan
- Possible side effects
- How to store Virgan
- Contents of the pack and other information
- What Virgan contains
- What Virgan looks like and contents of the pack
- Marketing authorization holder in Greece, the country of export:
- Manufacturer:
- Parallel importer:
- Repackaged by:
- Parallel import authorization number: 351/19
- This medicinal product is authorized in the Member States of the European Economic Area under the following names:
- Date of approval of the leaflet: 17.09.2024
Package Leaflet: Information for the User
Warning! Keep the leaflet. Information on the immediate packaging in a foreign language.
Virgan 1.5 mg/g eye gel
Ganciclovir
Read the leaflet carefully before using the medicine, as it contains important information for the patient.
- Keep this leaflet, so you can read it again if you need to.
- If you have any doubts, consult your doctor or pharmacist.
- This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
- If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.
Table of Contents of the Leaflet
- 1. What is Virgan and what is it used for
- 2. Important information before using Virgan
- 3. How to use Virgan
- 4. Possible side effects
- 5. How to store Virgan
- 6. Contents of the pack and other information
1. What is Virgan and what is it used for
Virgan is an eye gel containing the antiviral medicine ganciclovir. It is used to treat certain superficial and viral eye infections (of the cornea).
2. Important information before using Virgan
When not to use Virgan:
- during pregnancy and breastfeeding, unless the doctor recommends otherwise.
- in men and women of childbearing age who are not using a method of birth control. Additionally, men treated with Virgan are advised to use a local contraceptive method (e.g., a condom) during treatment and for three months after its completion. Women treated with Virgan are advised to use contraceptive measures during treatment and for six months after its completion.
Warnings and precautions
Before starting to use Virgan, discuss it with your doctor.
- Do not swallow.
- Avoid touching the eyes and eyelids with the dropper tip.
- Wearing contact lenses: Avoid contact between the medicine and soft contact lenses (see also Virgan contains benzalkonium chloride).
Children and adolescents
Due to the lack of detailed studies, the use of Virgan in children under 18 years of age is not recommended.
Virgan and other medicines
If the patient is using any other eye drops, they should:
first use the other eye medicine,
wait 15 minutes,
use Virgan as the last one.
Tell the doctor or pharmacist about all medicines the patient is taking or has recently taken, as well as any medicines they plan to take.
Pregnancy, breastfeeding, and fertility
The medicine should not be used during pregnancy and breastfeeding, unless the doctor recommends otherwise.
See also section 2: When not to use Virgan. If the patient is pregnant, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine. The doctor is the only person who can modify the treatment.
Driving and using machines
After administering the medicine, temporary blurred vision may occur. Wait until your vision returns to normal before driving or operating machinery.
Virgan contains benzalkonium chloride
This medicine contains 2.625 micrograms of benzalkonium chloride per drop of gel, which corresponds to 0.075 mg/g.
Benzalkonium chloride may be absorbed by soft contact lenses and may change the color of the contact lenses. Remove contact lenses before using this medicinal product and put them back 15 minutes later.
Benzalkonium chloride can also cause eye irritation, especially in the case of dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If the patient experiences any unusual reactions from the eye, stinging, or eye pain after using this medicine, they should tell their doctor.
3. How to use Virgan
Dosage
This medicine should always be used exactly as recommended by the doctor or pharmacist. If in doubt, consult the doctor or pharmacist.
The recommended dose of the medicine is 1 drop 3 to 5 times a day.
Use in children:
The use of this eye gel in children under 18 years of age is not recommended.
Method of administration
This medicine is intended for use in the eye (eye) that needs treatment (administration to the eye).
Before using the product, wash your hands thoroughly,
looking up, gently pull down the lower eyelid and squeeze the tube to drop the medicine into the infected eye,
close the tube after use.
Duration of treatment:
Treatment usually does not exceed 21 days.
Using more Virgan than recommended
Continue treatment as recommended by the doctor.
Consult a doctor or pharmacist immediately.
Missing a dose of Virgan
Do not use a double dose to make up for a missed dose.
If you have any further doubts about using this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, Virgan can cause side effects, although not everybody gets them.
Eye disorders:
Very common: may occur more often than in 1 in 10 people
- transient burning or stinging, eye irritation, blurred vision.
Common: may occur less often than in 1 in 10 people
- keratitis (punctate keratitis), conjunctival hyperemia (conjunctival injection).
Reporting side effects
If side effects occur, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Reporting side effects can help gather more information on the safety of the medicine.
5. How to store Virgan
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
No special precautions for storage.
After opening the tube of medicine, do not store it for more than 4 weeks.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
6. Contents of the pack and other information
What Virgan contains
- The active substance is ganciclovir. 1 gram of gel contains 1.5 mg of ganciclovir.
- The other ingredients are carbomer (Carbopol 974P), sorbitol, sodium hydroxide (to adjust the pH), benzalkonium chloride, and purified water.
What Virgan looks like and contents of the pack
Virgan is available in a tube containing 5 grams of gel.
For more detailed information, consult the marketing authorization holder or the parallel importer.
Marketing authorization holder in Greece, the country of export:
Laboratoires THÉA, 12, rue Louis Blériot, 63017 Clermont-Ferrand Cedex 2, France
Manufacturer:
Farmila-Thea Farmaceutici Spa, Via Enrico Fermi, 50, 20019 Settimo Milanese (MI), Italy
Parallel importer:
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Repackaged by:
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Greek marketing authorization number, country of export: 12135/03-02-2014
1596/11-01-2006
Parallel import authorization number: 351/19
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Czech Republic, France, Germany, Greece, Hungary, Italy, Luxembourg, Poland, Spain............VIRGAN
Date of approval of the leaflet: 17.09.2024
[Information about the trademark]
Page 4 4

- Country of registration
- Dosage formGel, 1.5 mg/g
- ATC codeS01AD09
- Active substance
- Prescription requiredYes
- Marketing authorisation holder (MAH)Laboratoires Thea
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Virgan 1,5 mg/g zhel do ohuDosage form: Gel, 1.5 mg/gActive substance: ganciclovirManufacturer: Fermila- Thea Farmaceutici S.p.A.Prescription requiredDosage form: Gel, 1.5 mg/gActive substance: ganciclovirPrescription requiredDosage form: Gel, 1.5 mg/gActive substance: ganciclovirPrescription required
Online doctors for Virgan 1,5 mg/g zhel do ohu
Discuss questions about Virgan 1,5 mg/g zhel do ohu, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get Virgan 1,5 mg/g zhel do ohu Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Virgan 1,5 mg/g zhel do ohu requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in Virgan 1,5 mg/g zhel do ohu is ganciclovir. This information helps identify medicines with the same composition but different brand names.
Virgan 1,5 mg/g zhel do ohu is manufactured by Laboratoires Thea. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Virgan 1,5 mg/g zhel do ohu is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy Virgan 1,5 mg/g zhel do ohu in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (ganciclovir) include Virgan 1,5 mg/g zhel do ohu, Virgan 1,5 mg/g zhel do ohu, Virgan 1,5 mg/g zhel do ohu. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
















